Prepare to overcome your supply issues in 2022 by developing a high-performing supply chain for the cGMP chemicals critical to your biologic manufacturing. Download now!
Moderna has suffered a blow in its patent feud with Arbutus Biopharma, exposing the mRNA specialist to a potential infringement suit on its megablockbuster COVID-19 vaccine.
The PerkinElmer Lead Discovery Premium Biotech Bundle empowers you to find and understand trends and outliers in your data to ensure successful candidate selection. On the AWS Cloud, affordable, easy to deploy. Learn more.
Vertex in October gained plaudits and criticism in equal measure when it released data showing a single patient in a trial of its diabetes cell therapy stopped needing insulin; this time around, it’s plugging another major breakthrough in a tiny test in kidney disease.
Merger and acquisition activity has been rather slow in the biopharma industry so far this year. But, by one team of analysts’ calculations, large drugmakers will have big piles of cash to deploy in 2022.
As we begin to enter the third year of the COVID-19 pandemic (yes, the third), there’s still work to be done and evermore opportunities for medtech companies to make substantial differences in every field of healthcare. So which companies will deliver?
The U.S. reports its first omicron variant case. The White House was blocked from enforcing two mandates requiring U.S. employees to get vaccinated. Plus more.
While the Biden administration's vaccine mandate remains in legal limbo, a new survey suggests many employers are rolling out such requirements anyway.
Scientists at Washington University discovered that by inhibiting a molecule called MK2, Aclaris Therapeutics’ experimental rheumatoid arthritis drug boosted the ability of chemo to kill pancreatic cancer cells. In mouse models of the disease, the combo shrank tumors and improved survival, they reported.
Trump-appointed judges from Louisiana and Illinois who issued preliminary injunctions against the vaccination mandates this week agreed that the requirements will harm plaintiff states and are unlikely to hold up in court.
Fierce Biotech profiles three women breaking barriers in Alzheimer's disease R&D at leading pharmaceutical companies. Today, Genentech's global head of neurodegeneration, Rachelle Doody.
While Sanofi hasn’t been at the forefront of global COVID-19 vaccination efforts, the company still has big growth expectations in the vaccines field. Already the world’s top flu shot player, Sanofi sees mRNA, pneumococcal vaccines and respiratory syncytial virus as three areas of opportunity going forward.
